Toho : Notice Regarding Relocation of Head Office Location(89 KB)
June 06, 2024
Share
June 7, 2024
To whom it may concern:
Company Name
TOHO HOLDINGS CO., LTD.
Corporate
Atsushi Udoh, Representative Director, CEO
Representative
(Prime Market of Tokyo Stock Exchange
Contact:
Securities Code: 8129)
Makoto Kawamura, Corporate Officer and
General Manager, Corporate Communications
and Investor Relations Division
(TEL: 81-3-6838-2803)
Notice Regarding Relocation of Head Office Location
TOHO HOLDINGS CO., LTD. is pleased to announce that, at Board of Directors meeting held today, it was decided to relocate the head office of the Company and its subsidiary as follows.
New Head Office Location
4-43-11, Daizawa, Setagaya-ku, Tokyo 155-8655, Japan (Reference)
Current Head Office Location
5-2-1, Daizawa, Setagaya-ku, Tokyo 155-8655, Japan
Date of Relocation July 23, 2024
Relocation Companies
TOHO HOLDINGS CO., LTD., TOHO PHARMACEUTICAL CO., LTD.
4. Reason of Relocation
Due to the aging of the building (Daizawa Main Building) where the head office is currently located under the
Articles of Incorporation, it will be relocated to the adjacent Daizawa New Building. The head office functions of the Company and Toho Pharmaceutical Co., Ltd. were consolidated and relocated to Tokyo Midtown Yaesu, Yaesu Central Tower (2-2-1 Yaesu, Chuo-ku, Tokyo) in December 2023.
5. Impact to consolidated financial results
The impact of this relocation on consolidated financial results is immaterial.
6. Other
There will be no changes to the Articles of Incorporation because the head office will be relocated within the same ward (Setagaya-ku, Tokyo).
Attachments
Original Link
Original Document
Permalink
Disclaimer
Toho Holdings Co. Ltd. published this content on
07 June 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
09 June 2024 23:57:06 UTC.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.